S5019 Ileal Tuberculosis Masquerading as Inflammatory Bowel Disease in a Patient With Protein-Losing Enteropathy: A Diagnostic Dilemma

Introduction: Ileal tuberculosis (TB) and Crohn’s disease can share overlapping clinical, endoscopic, and histopathological features, posing a diagnostic challenge, particularly in regions endemic to TB. We present a case of a 60-year-old man with ileal ulcers, small bowel obstruction, and protein-losing enteropathy, initially suspected as Crohn’s disease but later diagnosed as intestinal TB. Case Description/Methods: A 60-year-old man with type 2 diabetes, hypothyroidism, ischemic heart disease (post-PTCA, post-PPM), and hypertension presented with persistent hiccups, weight loss (∼4 kg in 3 weeks), anorexia, abdominal pain, vomiting, and hypoalbuminemia. He had a history of small bowel obstruction involving 2 ileal segments and post-polypectomy colonic changes. Labs revealed hypoalbuminemia (2.0–2.6 g/dL), low total protein (4.6 g/dL), and hyponatremia. Imaging showed hepatomegaly. Ileocolonoscopy revealed healed ileal ulcers and cecal scarring. Biopsies showed chronic inflammation with granulomas. GeneXpert® for MTB was negative. Based on histology and endemic context, empirical anti-tubercular therapy (AKURIT-T4) was initiated. He was concurrently treated with mesalamine (Pentasa), albucare powder, and symptom control agents. His symptoms, weight, and albumin levels improved (to 2.6–2.8 g/dL). Protein-losing enteropathy was monitored via urine ACR and 24-hour urinary protein. He remained hemodynamically stable on follow-up. Discussion: Intestinal TB often mimics Crohn’s disease with ileocecal ulcers and granulomas. However, TB typically presents with transverse ulcers, necrosis, and acute onset. Negative AFB or GeneXpert® does not exclude TB, especially in healed disease. Histology and clinical response to therapy guide diagnosis. This patient responded well to ATT within 6–8 weeks. Protein-losing enteropathy, though uncommon, can arise from chronic ileal inflammation. Persistent hiccups were likely due to diaphragmatic irritation or TB-related motility issues and resolved with treatment. Conclusion: In TB-endemic regions, intestinal tuberculosis should remain high on the differential for IBD-like presentations. Empirical ATT may be warranted in equivocal cases with supportive histology and epidemiological context. Accurate differentiation avoids unnecessary immunosuppression.

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001147536.53772.84
Primary Topic
Diagnosis and treatment of tuberculosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S5019 Ileal Tuberculosis Masquerading as Inflammatory Bowel Disease in a Patient With Protein-Losing Enteropathy: A Diagnostic Dilemma

The American Journal of Gastroenterology
Diagnosis and treatment of tuberculosis
article

S5019 Ileal Tuberculosis Masquerading as Inflammatory Bowel Disease in a Patient With Protein-Losing Enteropathy: A Diagnostic Dilemma

article en

Abstract

Introduction: Ileal tuberculosis (TB) and Crohn’s disease can share overlapping clinical, endoscopic, and histopathological features, posing a diagnostic challenge, particularly in regions endemic to TB. We present a case of a 60-year-old man with ileal ulcers, small bowel obstruction, and protein-losing enteropathy, initially suspected as Crohn’s disease but later diagnosed as intestinal TB. Case Description/Methods: A 60-year-old man with type 2 diabetes, hypothyroidism, ischemic heart disease (post-PTCA, post-PPM), and hypertension presented with persistent hiccups, weight loss (∼4 kg in 3 weeks), anorexia, abdominal pain, vomiting, and hypoalbuminemia. He had a history of small bowel obstruction involving 2 ileal segments and post-polypectomy colonic changes. Labs revealed hypoalbuminemia (2.0–2.6 g/dL), low total protein (4.6 g/dL), and hyponatremia. Imaging showed hepatomegaly. Ileocolonoscopy revealed healed ileal ulcers and cecal scarring. Biopsies showed chronic inflammation with granulomas. GeneXpert® for MTB was negative. Based on histology and endemic context, empirical anti-tubercular therapy (AKURIT-T4) was initiated. He was concurrently treated with mesalamine (Pentasa), albucare powder, and symptom control agents. His symptoms, weight, and albumin levels improved (to 2.6–2.8 g/dL). Protein-losing enteropathy was monitored via urine ACR and 24-hour urinary protein. He remained hemodynamically stable on follow-up. Discussion: Intestinal TB often mimics Crohn’s disease with ileocecal ulcers and granulomas. However, TB typically presents with transverse ulcers, necrosis, and acute onset. Negative AFB or GeneXpert® does not exclude TB, especially in healed disease. Histology and clinical response to therapy guide diagnosis. This patient responded well to ATT within 6–8 weeks. Protein-losing enteropathy, though uncommon, can arise from chronic ileal inflammation. Persistent hiccups were likely due to diaphragmatic irritation or TB-related motility issues and resolved with treatment. Conclusion: In TB-endemic regions, intestinal tuberculosis should remain high on the differential for IBD-like presentations. Empirical ATT may be warranted in equivocal cases with supportive histology and epidemiological context. Accurate differentiation avoids unnecessary immunosuppression.

The American Journal of GastroenterologyVol. 120(10S2)
Good health and well-being
Openalex Percentile: Top 29%
Diagnosis and treatment of tuberculosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.